午夜一级毛片-手机看片99-动漫人物桶机免费动漫app-日日摸日日碰夜夜97|www.zyjlr.com

TEL:020-31701980      FAX:020-31701979     E-mail:sales@mx008.com
China Mingxuan
Service Hotline:020-3171980
搜索

News
MX trends
industry trends
fair information
 
Micro-channel
 
Information details You are here:Home >> News >> industry trends
 
Premier: lower taxes! Cut card! Enterprise is not tang's monk meat!
 
Author:中國銘鉉 企劃部  Release Time:2017-7-3 15:56:26  Number Browse:518
 
Medical net on July 3 the health tax return good again! 
 
29 evening, the Chinese government network published the premier li keqiang, deepen the reform of the tube and to delegate put combined with optimization services nationwide television speech on a conference call, tax cuts, decrease the content of such closely related to the pharmaceutical industry is disclosed for the first time. 
 
These new tax cuts including simplified value-added tax rate structure, expanding our scope of small profit-making enterprises enjoy preferential enterprise income tax, improve the proportion of small and mid-sized enterprise research and development expenses claim additional deduction pre-tax, etc. 
 
Among them, the new measures include the cancellation of 41 central administrative fees and the elimination of a number of government-managed funds, such as special funds for industrial restructuring. 
 
In accordance with the information already published, we should fully implement the structural tax reduction policy. We will adhere to the law to curb taxes, reduce the discretionary power of taxation, increase transparency and prevent self-indulgent tax collection. 
 
In addition, the simplification of the structure of VAT rate, which has been simplified to three from four in this year, has changed the rate of the original 13% tax rate to an 11% tax rate. We will also implement preferential tax policies for small and medium-sized enterprises and continue to release larger tax cuts. 
 
In terms of the focus of this year's "administration of management", the meeting stressed that the tax reduction measures introduced this year could reduce the annual negative value of enterprises by more than 1 trillion yuan. 
 
Mr Li highlighted the reduction in fees for companies involved. 
 
"Enterprises now charge subject more, optional the gender is big, charging projects is multifarious, there are all kinds of levies and fines, not only increase the burden of enterprises, deteriorated the business environment, also affect corporate investment confidence. To this, must punch governance, resolutely cut 'disorderly stretch hand to enterprises', not allowed to take enterprise as''s flesh." Li keqiang said. 
 
According to shen wan data, the income tax rate of enterprises paid by traditional industries is significantly higher than that of emerging industries: the current corporate income tax rate is 25%, 20%, 15% and 10%. One of the companies with a higher income tax rate of 25 per cent has a higher proportion of companies in the traditional sectors. After the increase of the battalion, the medical circulation industry was first experienced in the short-term tax burden increase. 
 
Public information, the lack of pharmaceutical r&d tax preferential policies, the state r&d claim additional deduction of incentives, but there are challenges in the concrete practice, makes a lot of major research and development type drug firms is less than half of the r&d can enjoy preferential, for a lot of financial system is not sound a greater role in small and medium-sized enterprises. 
 
It is understood that the next step will be to further reduce the and promote the "licenses" focused greatly ease market access, and promote the reform of "separation" awarded the broader, in addition to involving national security, public safety, ecological safety and public health and other major public interests, the "card" that can separate permission class are separate, respectively to cancel or change to put on record, promised to inform management way, such as in handling the business license for enterprise as soon as possible after opening. 
 
Previous article:The 135th drug accident involving novartis, Merck, shi guibao, tong ren tang
Next article:How to change the market pattern of anti-tumor drug in China after multiple heavy pound imported drugs?
 
Log in  Website Map All right reserved by China Mingxuan, Guangzhou ICP #16026227
    

粵公網安備 44011202000029號